全文获取类型
收费全文 | 38513篇 |
免费 | 2481篇 |
国内免费 | 14篇 |
专业分类
41008篇 |
出版年
2023年 | 224篇 |
2022年 | 521篇 |
2021年 | 907篇 |
2020年 | 518篇 |
2019年 | 673篇 |
2018年 | 939篇 |
2017年 | 784篇 |
2016年 | 1315篇 |
2015年 | 1993篇 |
2014年 | 2139篇 |
2013年 | 2931篇 |
2012年 | 3354篇 |
2011年 | 3194篇 |
2010年 | 1951篇 |
2009年 | 1682篇 |
2008年 | 2387篇 |
2007年 | 2321篇 |
2006年 | 2063篇 |
2005年 | 1855篇 |
2004年 | 1743篇 |
2003年 | 1681篇 |
2002年 | 1519篇 |
2001年 | 306篇 |
2000年 | 215篇 |
1999年 | 298篇 |
1998年 | 380篇 |
1997年 | 256篇 |
1996年 | 253篇 |
1995年 | 231篇 |
1994年 | 224篇 |
1993年 | 219篇 |
1992年 | 135篇 |
1991年 | 146篇 |
1990年 | 148篇 |
1989年 | 109篇 |
1988年 | 100篇 |
1987年 | 91篇 |
1986年 | 70篇 |
1985年 | 95篇 |
1984年 | 97篇 |
1983年 | 72篇 |
1982年 | 84篇 |
1981年 | 80篇 |
1980年 | 80篇 |
1979年 | 74篇 |
1978年 | 39篇 |
1977年 | 51篇 |
1976年 | 37篇 |
1975年 | 39篇 |
1973年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Fluoro‐Sorafenib (Regorafenib) effects on hepatoma cells: Growth inhibition,quiescence, and recovery
Brian I. Carr Aldo Cavallini Catia Lippolis Rosalba D'Alessandro Caterina Messa Maria G. Refolo Angela Tafaro 《Journal of cellular physiology》2013,228(2):292-297
To evaluate the growth‐inhibitory properties of the potent multi‐kinase antagonist Regorafenib (Fluoro‐Sorafenib), which was synthesized as a more potent Sorafenib, a Raf inhibitor and to determine whether similar mechanisms were involved, human hepatoma cell lines were grown in the presence or absence of Regorafanib and examined for growth inhibition. Western blots were performed for Raf targets, apoptosis, and autophagy. Regorafenib inhibited growth of human Hep3B, PLC/PRF/5, and HepG2 cells in a concentration‐ and time‐dependent manner. Multiple signaling pathways were altered, including MAP kinases phospho‐ERK and phospho‐JNK and its target phospho‐c‐Jun. There was evidence for apoptosis by FACS, cleavage of caspases and increased Bax levels; as well as induction of autophagy, as judged by increased Beclin‐1 and LC3 (II) levels. Prolonged drug exposure resulted in cell quiescence. Full growth recovery occurred after drug removal, unlike with doxorubicin chemotherapy. Regorafenib is a potent inhibitor of cell growth. Cells surviving Regorafenib treatment remain viable, but quiescent and capable of regrowth following drug removal. The reversibility of tumor cell growth suppression after drug removal may have clinical implications. J. Cell. Physiol. 228: 292–297, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
992.
Annalisa Vilasi Silvia Vilasi Rocco Romano Fausto Acernese Fabrizio Barone Maria Luisa Balestrieri Rosa Maritato Gaetano Irace Ivana Sirangelo 《Journal of cellular physiology》2013,228(6):1359-1367
A range of debilitating human diseases is known to be associated with the formation of stable highly organized protein aggregates known as amyloid fibrils. The early prefibrillar aggregates behave as cytotoxic agents and their toxicity appears to result from an intrinsic ability to impair fundamental cellular processes by interacting with cellular membranes, causing oxidative stress and increase in free Ca2+ that lead to apoptotic or necrotic cell death. However, specific signaling pathways that underlie amyloid pathogenicity remain still unclear. This work aimed to clarify cell impairment induced by amyloid aggregated. To this end, we used a combined proteomic and one‐dimensional 1H‐NMR approach on NIH‐3T3 cells exposed to prefibrillar aggregates from the amyloidogenic apomyoglobin mutant W7FW14F. The results indicated that cell exposure to prefibrillar aggregates induces changes of the expression level of proteins and metabolites involved in stress response. The majority of the proteins and metabolites detected are reported to be related to oxidative stress, perturbation of calcium homeostasis, apoptotic and survival pathways, and membrane damage. In conclusion, the combined proteomic and 1H‐NMR metabonomic approach, described in this study, contributes to unveil novel proteins and metabolites that could take part to the general framework of the toxicity induced by amyloid aggregates. These findings offer new insights in therapeutic and diagnostic opportunities. J. Cell. Physiol. 228: 1359–1367, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
993.
Marco Rossi Maria Rita Pitari Nicola Amodio Maria Teresa Di Martino Francesco Conforti Emanuela Leone Cirino Botta Francesco Maria Paolino Teresa Del Giudice Eleonora Iuliano Michele Caraglia Manlio Ferrarini Antonio Giordano Pierosandro Tagliaferri Pierfrancesco Tassone 《Journal of cellular physiology》2013,228(7):1506-1515
994.
995.
Alberto Martire Rita Pepponi Maria Rosaria Domenici Antonella Ferrante Valentina Chiodi Patrizia Popoli 《Journal of neurochemistry》2013,125(2):225-235
NMDA receptor‐mediated excitotoxicity is thought to play a pivotal role in the pathogenesis of Huntington's disease (HD). The neurotrophin brain‐derived neurotrophic factor (BDNF), which is also highly involved in HD and whose effects are modulated by adenosine A2ARs, influences the activity and expression of striatal NMDA receptors. In electrophysiology experiments, we investigated the role of BDNF toward NMDA‐induced effects in HD models, and the possible involvement of A2ARs. In corticostriatal slices from wild‐type mice and age‐matched symptomatic R6/2 mice (a model of HD), NMDA application (75 μM) induced a transient or a permanent (i.e., toxic) reduction of field potential amplitude, respectively. BDNF (10 ng/mL) potentiated NMDA effects in wild‐type, while it protected from NMDA toxicity in R6/2 mice. Both effects of BDNF were prevented by A2AR blockade. The protective effect of BDNF against NMDA‐induced toxicity was reproduced in a cellular model of HD. These findings may have very important implications for the neuroprotective potential of BDNF and A2AR ligands in HD. 相似文献
996.
Eukaryotic translation elongation factor 2 (eEF2) facilitates the movement of the peptidyl tRNA-mRNA complex from the A site of the ribosome to the P site during protein synthesis. ADP-ribosylation (ADPR) of eEF2 by bacterial toxins on a unique diphthamide residue inhibits its translocation activity, but the mechanism is unclear. We have employed a hormone-inducible diphtheria toxin (DT) expression system in Saccharomyces cerevisiae which allows for the rapid induction of ADPR-eEF2 to examine the effects of DT in vivo. ADPR of eEF2 resulted in a decrease in total protein synthesis consistent with a defect in translation elongation. Association of eEF2 with polyribosomes, however, was unchanged upon expression of DT. Upon prolonged exposure to DT, cells with an abnormal morphology and increased DNA content accumulated. This observation was specific to DT expression and was not observed when translation elongation was inhibited by other methods. Examination of these cells by electron microscopy indicated a defect in cell separation following mitosis. These results suggest that expression of proteins late in the cell cycle is particularly sensitive to inhibition by ADPR-eEF2. 相似文献
997.
998.
Liisa M. Uotila Maria Aatonen Carl G. Gahmberg 《The Journal of biological chemistry》2013,288(46):33494-33499
CD11c/CD18 (αXβ2, p150/95, or complement receptor 4, CR4) is a monocyte/macrophage-enriched integrin that has been reported to bind to a variety of ligands. These include cell surface proteins, extracellular matrix proteins, and soluble ligands. The regulation of ligand binding to CD11c/CD18 has remained poorly understood. Previous work has shown that both α-chain and β-chain phosphorylations of CD11a/CD18 and CD11b/CD18 are needed for activity, but no corresponding studies on CD11c/CD18 have been performed. In this study, we have identified the phosphorylation site of CD11c as Ser-1158 and show that it is pivotal for adherence and phagocytosis. 相似文献
999.
1000.